Anakinra (
Kineret®) is a prescription medication used to treat
rheumatoid arthritis. Specifically, it is approved to treat moderate to severe rheumatoid
arthritis in people who have not adequately responded to other rheumatoid
arthritis medications. It is given as a daily injection just under the skin.
Anakinra is made by Amgen, Inc.
People with rheumatoid arthritis often have high levels of a certain protein called interleukin-1 (IL-1) in their joints. IL-1 causes inflammation, cartilage damage, and bone erosion. Anakinra is a synthetic form of a different naturally occurring protein in the body that inhibits the effects of IL-1. By binding to IL-1, anakinra can help reduce the symptoms of rheumatoid arthritis, along with the physical damage to the joints.
Because anakinra targets a specific part of the immune system (IL-1), it is called a "biological response modifier" because it changes (modifies) the body's immune response. It is also known as a "biologic" medication, because it is a protein.